• About
  • Subscribe
  • Advertise
  • Contact
Monday, July 13, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Profit driven health funds concern ASO president

by Staff Writer
October 11, 2019
in News
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

Sumich, who said the ASO exists to protect – and when necessary, fight for – high quality, accessible ophthalmology services, also accused private health insurers of wanting to adopt a US-style healthcare model at the expense of Australian patients.“At present we have private health funds that are more profitable than the banks and these same stock market listed entities are blaming everyone but thselves for rising annual priums,” he said.{{quote-a:r-w:425-I:2-Q:“Whilst they are bathing in rivers of gold it is their shareholders who are reaping the rewards that come from higher priums and the government rebate that underwrites th.”-WHO:Peter Sumich, ASO president}}“Whilst they are bathing in rivers of gold it is their shareholders who are reaping the rewards that come from higher priums and the government rebate that underwrites th.“The stated goal of private health insurers is to introduce US-style ‘managed’ or ‘Network Care’, or whatever other euphism they will name it. This will deliver a restrictive product that limits patient choices – and choice, of course, is the very reason Australians take out private health cover in the first place,” Sumich explained.However, the new CEO of peak advocacy body Private Healthcare Australia (PHA), Dr Rachel David, disagreed and pointed to data from the Australian Prudential Regulation Authority (APRA) to illustrate her point.“Health fund profit margins have rained stable over the last decade running between 4.5–6%. This is a modest return when compared with other forms of insurance. It is also significantly below the returns made by procedural medical specialist practices,” she said.“Managent expense ratios have trended down consistently over the last 15 years, and have currently declined to 8.9% while the profit margin of funds, which is reported to our regulator APRA on a regular basis, is at 5.13%, and has rained stable over the last 10–15 years.”David also described Sumich’s assertion that private health funds were looking to introduce US-style managed care as “fiction”, and cited data from the most recent Ipsos healthcare and insurance survey which indicated 84% of private policy holders felt they received value for money.“Contrary to claims that some funds are restricting cover, health funds want their mbers to understand their policy and to have the appropriate cover for every stage of life. Health funds invested millions of dollars towards improving transparency during the PHI [private health insurance] reform process, to develop policies to simplify consumer choice and not add to complexity or upward pressure on priums,” David said.“Upward pressure on priums is due to input costs, utilisation and health inflation, the key elents of which are hospital accommodation, specialist gap cover, allied health cover and medical devices.”Sumich said while he thought the recently announced private health insurance reforms made some progress, the issue of discrimination against patient choice rained unacceptable.{{quote-a:r-w:400-I:3-Q:“Upward pressure on priums is due to input costs, utilisation and health inflation, the key elents of which are hospital accommodation, specialist gap cover, allied health cover and medical devices.”-WHO:Rachel David, PHA CEO}}“It is wrong that two patients with the exact same health insurance will receive a different private procedure rebate by a factor of up to three times, depending on which surgeon they choose – the contracted network doctor or the non-contracted free agent. The patient should not be penalised with a larger gap because they wanted their own surgeon,” he said.“With respect to managed care, we see evidence that private health insurers are creating preferred provider networks with ‘carrot and stick’ arrangents for doctors and patients. Patients who do not use a gap cover provider are financially penalised, and are receiving differential benefits even if they have the same health care policies.”According to the ASO president, patients are also receiving letters from insurers informing th that they local day surgery is not a ‘contracted hospital’, which ha said caused distress for both th and the day surgery owners.“All taken together it may not be managed care by legislation, but it acts the same way in the marketplace,” Sumich added.However, despite the criticism, David defended the practice and said the reason health funds contract with doctors is to give patients certainty about out-of-pocket expenses.“Without a strong focus on affordability and value, consumer support of private health will decline to the point where everyone will lose out,” she said.Currently, 13.5 million Australians are covered by private insurance, more than half of who have disposable annual incomes of less than $50,000.Image courtesy: Flickr | Franchise Opportunities

Related Posts

UNSW has achieved a top ranking. Image: UNSW.

UNSW named No. 1 in world for optometry research excellence

by Staff Writer
July 9, 2026

The UNSW School of Optometry & Vision Science has been recognised as the world's leading optometry school for research excellence,...

Doctors have a key role to play in eye health, according to the RACGP. Image: Graphic PNG Grid/stock.adobe.com.

GPs key to preventing avoidable vision loss, says RACGP

by Rob Mitchell
July 8, 2026

The Royal Australian College of GPs (RACGP) is highlighting the vital role GPs play in protecting Australians’ sight, with the July...

CooperVision said new APAC president Muru Annamalai was an experienced global healthcare leader. Image: CooperVision.

CooperVision names Muru Annamalai as APAC president

by Helen Carter
July 8, 2026

CooperVision has named Muru Annamalai as president, Asia-Pacific, stating the experienced global healthcare leader will guide growth across the region....

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited